ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection
Completed · Phase 3 · Has a placebo group
Conditions studied: Clostridium Difficile Infection
In brief
Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo once daily for 3 consecutive days in Treatment Group II. The purpose of this study is to demonstrate the superiority of SER-109 vs placebo to reduce recurrence of CDI as determined by a toxin assay in adults up to 8 weeks after initiation of treatment.
Key facts
- Study ID
- NCT03183128
- Run by
- Seres Therapeutics, Inc.
- People needed
- 182
- Starts
- 2017-07-10
- Expected to finish
- 2020-09-29
- Last updated by the study team
- 2023-04-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- (Investigator site) — Mather, California, United States
- (Investigator site) — Mountain View, California, United States
- (Investigator site) — Northridge, California, United States
- (Investigator site) — Sacramento, California, United States
- (Investigator site) — Simi Valley, California, United States
- (Investigator site) — Upland, California, United States
- (Investigator site) — Hamden, Connecticut, United States
- (Investigator site) — Washington D.C., District of Columbia, United States
- (Investigator site) — Jacksonville, Florida, United States
- (Investigator site) — Miami, Florida, United States
- (Investigator site) — Miami, Florida, United States
- (Investigator site) — Pembroke Pines, Florida, United States
- (Investigator site) — Pembroke Pines, Florida, United States
- (Investigator site) — Athens, Georgia, United States
- (Investigator site) — Atlanta, Georgia, United States
- (Investigator site) — Marietta, Georgia, United States
- (Investigator site) — Riverdale, Georgia, United States
- (Investigator site) — Sandy Springs, Georgia, United States
- (Investigator site) — Idaho Falls, Idaho, United States
- (Investigator site) — Springfield, Illinois, United States
- (Investigator site) — Evansville, Indiana, United States
- (Investigator site) — Jeffersonville, Indiana, United States
- (Investigator site) — Iowa City, Iowa, United States
- (Investigator site) — Kansas City, Kansas, United States
- (Investigator site) — North Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.